TY  - GEN
AU  - Martín,Miguel
AU  - Ruiz Simón,Amparo
AU  - Ruiz Borrego,Manuel
AU  - Ribelles,Nuria
AU  - Rodríguez-Lescure,Álvaro
AU  - Muñoz-Mateu,Montserrat
AU  - González,Sonia
AU  - Margelí Vila,Mireia
AU  - Barnadas,Agustí
AU  - Ramos,Manuel
AU  - Del Barco Berron,Sonia
AU  - Jara,Carlos
AU  - Calvo,Lourdes
AU  - Martínez-Jáñez,Noelia
AU  - Mendiola Fernández,César
AU  - Rodríguez,César A
AU  - Martínez de Dueñas,Eduardo
AU  - Andrés,Raquel
AU  - Plazaola,Arrate
AU  - de la Haba-Rodríguez,Juan
AU  - López-Vega,Jose Manuel
AU  - Adrover,Encarna
AU  - Ballesteros,Ana Isabel
AU  - Santaballa,Ana
AU  - Sánchez-Rovira,Pedro
AU  - Baena-Cañada,José M
AU  - Casas,Maribel
AU  - del Carmen Cámara,María
AU  - Carrasco,Eva Maria
AU  - Lluch,Ana
TI  - Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study
SN  - 1527-7755
PY  - 2016///0212
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Capecitabine
KW  - administration & dosage
KW  - Chemotherapy, Adjuvant
KW  - Cyclophosphamide
KW  - Disease-Free Survival
KW  - Docetaxel
KW  - Drug Administration Schedule
KW  - Epirubicin
KW  - Female
KW  - Fluorouracil
KW  - Follow-Up Studies
KW  - Humans
KW  - Lymph Nodes
KW  - pathology
KW  - Lymphatic Metastasis
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Odds Ratio
KW  - Taxoids
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2015.61.9510
ER  -